A randomised, double-blind study carried out on 220 children affected by moderate/severe AD, showed that the oral administration of Lactobacillus paracasei and Lactobacillus fermentum, for 3 weeks led to decreased IgE, TNF-α, urine eosinophilic protein X and SCORAD scores. This evidence concerns the gene IGHE and Alzheimer disease.